DaTSCAN: Clinical Trials

10 trials of DaTSCAN, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 recruiting, 1 terminated. 2 Phase 2, 2 Phase 3, 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 32Completed 1, Withdrawn 1
Early Phase 11Completed 1
Not applicable1Completed 1

Follow DaTSCAN: new trials by email Literature Review of DaTSCAN trials Research Report on DaTSCAN

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Markers of Disease Progression and Gait Within the Parkinsonian Population
The FeetMe® Evaluation, the PKG® Watch,, MRI - Parkinson Disease
Not applicableCompletedUniversity Hospital, Lille832020-12-222025-12-04
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
DaTscan, F18-AV-45, FDG-PET - Alzheimer's Disease, Lewy Body Dementia
RecruitingDouglas Scharre762018-08-302026-10-15
Idiopathic Parkinson's Progression and Dopamine Transporter SPECT
Ioflupane I 123 - Parkinson Disease
CompletedJulie Gurwell122018-01-192022-11-17
Diagnostic Imaging for Clear Cell Renal Cell Carcinoma
Ioflupane I123 - Clear Cell Renal Cell Carcinoma
Phase 2TerminatedRegion Skane52017-07-142019-06-21
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
NAV5001, DaTscan - Parkinson's Syndrome
Phase 3WithdrawnNavidea Biopharmaceuticals2017-04-012017-09-13
Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
[18F]MNI-958, [18F]Florbetapir, DaTscan - Alzheimer Disease, Healthy Volunteers
Early Phase 1CompletedMolecular NeuroImaging122016-11-292019-03-25
Nigrosomal Iron Imaging in Parkinson's Disease
Patient assessment, DATScan, Orbital X-Ray - Parkinson Disease
UnknownUniversity of Nottingham1452016-06-012018-10-12
Validation of DaTscan for Detection of Parkinson Disease Related Disorders
l-123 Ioflupane - Parkinson Disease, Movement Disorders
UnknownWisconsin Institute for Neurologic and Sleep Disorders S.C.202014-07-012014-07-16
Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
DaTscan - Parkinson Disease
Phase 2CompletedKen Marek, MD9522010-06-012023-11-14
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
DatSCAN - Lewy Body Dementia, Non-DLB Dementia
Phase 3CompletedGE Healthcare3262003-11-012007-05-16

Conditions studied

Parkinson Disease (7)  ·  Alzheimer Disease (2)  ·  Disease (2)  ·  Lewy Body Disease (2)  ·  Carcinoma, Renal Cell (1)  ·  Dementia, Vascular (1)  ·  Mobility Limitation (1)  ·  Movement Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Supranuclear Palsy, Progressive (1)

Sponsors

Douglas Scharre (1)  ·  GE Healthcare (1)  ·  Julie Gurwell (1)  ·  Ken Marek, MD (1)  ·  Molecular NeuroImaging (1)  ·  Navidea Biopharmaceuticals (1)  ·  Region Skane (1)  ·  University Hospital, Lille (1)  ·  University of Nottingham (1)  ·  Wisconsin Institute for Neurologic and Sleep Disorders S.C. (1)

Countries

United States (6)  ·  France (2)  ·  Germany (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Greece (1)  ·  Israel (1)  ·  Italy (1)  ·  Norway (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Andrew Singleton, PhD (1)  ·  Arthur W. Toga, PhD (1)  ·  Caroline Moreau, MD,PhD (1)  ·  Christopher Coffey, PhD (1)  ·  Cornelia Reininger, M.D. Ph.D. (1)  ·  Douglas W Scharre, MD (1)  ·  John P Seibyl, MD (1)  ·  John Q. Trojanowski, MD, PhD (1)  ·  Julie Gurwell, PhD, PA-C (1)  ·  Karl Kieburtz, MD (1)  ·  Kenneth L Marek, MD (1)  ·  Marc Pignot, PhD (1)  ·  Paul A Nausieda, MD (1)  ·  Peter Elfving, M.D. PhD (1)

Results publications

PMID 24993764, PMID 25710187, PMID 26534930, PMID 28958801, PMID 28986467, PMID 29247084, PMID 31678032, PMID 32073681, PMID 33790041, PMID 36849448, PMID 37332638, PMID 37451695, PMID 37491235, PMID 37586882, PMID 38169864, PMID 39043465, PMID 39627057, PMID 39644799, PMID 40164470, PMID 40626875, PMID 40705614, PMID 41094519, PMID 41453126, PMID 42393590

NIH funding

2016 (1)